The utilization of AI in clinical trials holds great potential to advance the drug development process, aid in identifying ideal patients for trials, and recognize potential adverse effects related to treatment. By integrating real-world data analytics, researchers can derive valuable insights that bolster trial design and increase the likelihood of success. From a commercial standpoint, pharmaceutical companies can leverage the power of AI and data analytics to realize substantial cost savings